Navigation Links
Doctors Test Advanced Tool for Treating Prostate Cancer
Date:10/27/2008

Technology Designed to Confirm Precise Brachytherapy Treatment

ST. LOUIS, Oct. 27 /PRNewswire/ -- Leading radiation oncologists are using the TargetScan Touch(TM) system to deliver radioactive seed therapy in the prostate. The innovative technology is based on a motionless probe which stabilizes the prostate during procedures. With the gland stabilized, physicians use a touch-screen interface and 3-D ultrasound images to map and confirm placement of radiation.

Unveiled recently at the 2008 American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting, the TargetScan Touch(TM) has been tested at several of the nation's leading medical centers, including Emory University School of Medicine.

"This technology delivers two important benefits. First, a stabilized prostate; second, the ability to quickly and efficiently image anywhere in the prostate with the point and click function for accurate positioning of radioactivity," explains Peter Rossi, M.D., Emory's assistant professor in the departments of radiation oncology and urology. "TargetScan has a short learning curve for my residents and physicists and has demonstrated its value in that we have consistently achieved quality implants with its help."

Just launched, the system will initially be in clinical use at Emory, Washington University Medical Center in St. Louis, University of Florida and New Hanover Radiation Oncology.

The system is based on the TargetScan(R) technology platform developed by Envisioneering Medical Technologies in St. Louis, under the guidance of physicians at Washington University. "Traditional hand-manipulated devices allow the prostate gland to shift, which impedes placement accuracy. By stabilizing the prostate, physicians can now implant seeds to any and every region of the gland with greater confidence," said Robert Mills, president, Envisioneering Medical Technologies.

Other system features include intuitive imaging and n
'/>"/>

SOURCE Envisioneering Medical Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The Doctors Company Launches Litigation Education Retreats to Assist Physicians Involved in Medical Litigation
2. Doctors Lack Smoking Cessation Training
3. Doctors Often Overestimate Patients Health Literacy
4. MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource
5. Research suggests doctors should consider kidney-sparing surgery
6. Will patients stick to physical therapy? Questionnaire can help doctors predict
7. Help for Stutterers on The Doctors TV Show Presented by Power Stuttering Center Founder Mark Power
8. Maternity Care Doctors to Call for Renewal of MCARE Abatement Fund, Address Growing Shortage of Maternity Care Physicians
9. For Some Doctors, Empathy Is in Short Supply
10. Many Doctors Dont Know Blood Pressure Guidelines
11. UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Aurora, CO (PRWEB) November 26, 2014 For ... fast, the new LES MILLS BODYPUMP™ classes at ... be just the workout they've been looking for. The 45- ... with CU Anschutz Health and Wellness Center fitness club memberships. ... muscles. The workouts are fast-paced and are aimed at fast ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
(Date:11/26/2014)... -- Exposure to peanut protein in household dust may ... the skin condition eczema, a new study reveals. ... States are allergic to peanuts. And severe eczema in ... allergy, the researchers noted. The new study included ... researchers examined the amount of peanut protein the children ...
Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... opposite trend, latest one reflects entire U.S. population, experts ... some recent research has documented an upswing in mastectomy ... cancer, a new study comes to a different conclusion. ... decrease overall nationwide," said study author Dr. Elizabeth Habermann, ...
... ... Appeal and Wellness Benefits for Gamers , ... Los Angeles, CA (Vocus) June 15, 2010 -- Beamz Interactive , an ... of all ages and skill levels to play music, today announced a strategic partnership with ...
... the June edition of the Journal of Thoracic ... surgical outcomes of patients with non-small cell lung cancer ... cancer continues to rise; therefore, countermeasures to decrease death ... analyzing the time trends, researchers postulated that the increase ...
... This ... style and function are now standard accessories for most dog owners. The Rubit! provides a quick ... or the danger of a broken fingernail.The clip functions between the collar and an ID tags ... (PRWEB) June 15, 2010 ...
... new cancer medication sorafenib looks promising. Sorafenib is used ... to be effective against cancer stem cells in pancreatic ... Head of the Department of Molecular Oncosurgery, a group ... (Managing Director: Professor Dr. Markus W. Bchler) in cooperation ...
... reason why depression and other stress-related psychiatric disorders are ... signaling systems in animal brains, neuroscience researchers found that ... important stress hormone and less able to adapt to ... evidence for sex differences in how neurotransmitter receptors traffic ...
Cached Medicine News:Health News:Mastectomy Rates Down Overall, New Study Finds 2Health News:Mastectomy Rates Down Overall, New Study Finds 3Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 2Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 3Health News:Beamz Announces Partnership with Dynaflex International at E3 Expo 4Health News:Lung cancer research concludes that early diagnosis as key for improving survival 2Health News:The Rubit Dog Tag Clips Making Big Pet Store Sales, Everyday Dog Ownership Easier, Preventing Broken Fingernails. 2Health News:New combination effective against pancreatic cancer 2Health News:Higher anxiety, depression among women may have basis in cell signals 2
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... YORK, Pa. , Nov. 25, 2014  Unilife ... supplier of injectable drug delivery systems, today announced that ... scheduled to present at the Piper Jaffray 26th Annual ... 8:30 a.m. EST on Tuesday, December 2, 2014. ... the Internet as a "live" listen only Webcast. To ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 ... (NYSE: AZN ) today announced that AMAGINE-2 TM ... of brodalumab in more than 1,800 patients with moderate-to-severe plaque ... ® (ustekinumab) and placebo at week 12. Brodalumab 210 ... group were each shown to be superior to Stelara on ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... UPI ) announced today that it will release financial ... at the market close on Monday, November 2, 2009. ... results on Monday, November 2, 2009 at 3:30 p.m. Central ... Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will ...
... 21 Shire plc,(LSE: SHP, NASDAQ: SHPGY ), ... Biologics License Application (BLA) with the U.S.,Food and Drug ... for Fabry disease, by the end of the year. ... filed at the,request of FDA, has been approved, and ...
Cached Medicine Technology:Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: